MODERNA INC (0QF.DE) Stock Price & Overview
FRA:0QF • US60770K1079
Current stock price
The current stock price of 0QF.DE is 43.63 EUR. Today 0QF.DE is down by -6.45%. In the past month the price decreased by -5.8%. In the past year, price increased by 78.52%.
0QF.DE Key Statistics
- Market Cap
- 17.303B
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -6.21
- Dividend Yield
- N/A
0QF.DE Stock Performance
0QF.DE Stock Chart
0QF.DE Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to 0QF.DE. When comparing the yearly performance of all stocks, 0QF.DE is one of the better performing stocks in the market, outperforming 92.99% of all stocks.
0QF.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to 0QF.DE. 0QF.DE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
0QF.DE Earnings
On February 13, 2026 0QF.DE reported an EPS of -2.11 and a revenue of 678.00M. The company beat EPS expectations (21.71% surprise) and beat revenue expectations (6.17% surprise).
0QF.DE Forecast & Estimates
30 analysts have analysed 0QF.DE and the average price target is 38.76 EUR. This implies a price decrease of -11.17% is expected in the next year compared to the current price of 43.63.
For the next year, analysts expect an EPS growth of 1.99% and a revenue growth 10.33% for 0QF.DE
0QF.DE Groups
Sector & Classification
0QF.DE Financial Highlights
Over the last trailing twelve months 0QF.DE reported a non-GAAP Earnings per Share(EPS) of -6.21. The EPS increased by 21.66% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -22.87% | ||
| ROE | -32.62% | ||
| Debt/Equity | 0.07 |
0QF.DE Ownership
0QF.DE Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 1AE | ARGENX SE | 28.81 | 41.518B | ||
| ARGX | ARGENX SE | 28.75 | 41.431B | ||
| 22UA | BIONTECH SE-ADR | N/A | 22.62B | ||
| 2X1 | ABIVAX SA | N/A | 7.62B | ||
| ABVX | ABIVAX SA | N/A | 7.612B | ||
| GXE | GALAPAGOS NV | N/A | 1.607B | ||
| GLPG | GALAPAGOS NV | N/A | 1.605B | ||
| NANO | NANOBIOTIX | N/A | 1.361B | ||
| PHGN | PHARMING GROUP NV | 47.2 | 1.009B | ||
| PHARM | PHARMING GROUP NV | 46.97 | 1.004B | ||
| DBV | DBV TECHNOLOGIES SA | N/A | 946.39M | ||
| DBV | DBV TECHNOLOGIES SA | N/A | 932.473M | ||
| IVA | INVENTIVA SA | N/A | 907.693M |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About 0QF.DE
Company Profile
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The company is headquartered in Cambridge, Massachusetts and currently employs 4,700 full-time employees. The company went IPO on 2018-12-07. The firm is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). The company is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a spectrum of diseases. The Company’s diverse development pipeline consists of 44 therapeutic and vaccine programs, 11 of which are in late-stage development. Its commercial products include Spikevax (its COVID vaccine) and mRESVIA (its respiratory syncytial virus (RSV) vaccine). Additionally, it has achieved four positive Phase III data readouts for its COVID vaccine (mRNA-1283), its RSV vaccine for high-risk adults aged 18 to 59 (mRNA-1345), its seasonal flu+COVID vaccine (mRNA-1083), and its seasonal flu vaccine (mRNA-1010).
Company Info
IPO: 2018-12-07
MODERNA INC
325 Binney Street
Cambridge MASSACHUSETTS US
Employees: 4700
Phone: 16177146500
MODERNA INC / 0QF.DE FAQ
Can you describe the business of MODERNA INC?
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The company is headquartered in Cambridge, Massachusetts and currently employs 4,700 full-time employees. The company went IPO on 2018-12-07. The firm is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). The company is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a spectrum of diseases. The Company’s diverse development pipeline consists of 44 therapeutic and vaccine programs, 11 of which are in late-stage development. Its commercial products include Spikevax (its COVID vaccine) and mRESVIA (its respiratory syncytial virus (RSV) vaccine). Additionally, it has achieved four positive Phase III data readouts for its COVID vaccine (mRNA-1283), its RSV vaccine for high-risk adults aged 18 to 59 (mRNA-1345), its seasonal flu+COVID vaccine (mRNA-1083), and its seasonal flu vaccine (mRNA-1010).
What is the stock price of MODERNA INC today?
The current stock price of 0QF.DE is 43.63 EUR. The price decreased by -6.45% in the last trading session.
Does MODERNA INC pay dividends?
0QF.DE does not pay a dividend.
What is the ChartMill technical and fundamental rating of 0QF stock?
0QF.DE has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Where is MODERNA INC (0QF.DE) stock traded?
0QF.DE stock is listed on the Frankfurt Stock Exchange exchange.
What is MODERNA INC worth?
MODERNA INC (0QF.DE) has a market capitalization of 17.30B EUR. This makes 0QF.DE a Large Cap stock.